{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:13:56Z","timestamp":1787238836488,"version":"build-2736575974"},"reference-count":122,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,8]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose of review<\/jats:title>\n                    <jats:p>The goal of this review is to give an overview of diagnosis and up-to-date management of major pediatric metabolic bone diseases that are associated with bone fragility, including nutritional rickets, hypophosphatemic rickets, osteogenesis imperfecta, Ehlers--Danlos syndrome, Marfan's syndrome, hypophosphatasia, osteopetrosis and skeletal fluorosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent findings<\/jats:title>\n                    <jats:p>During the past decade, a number of advanced treatment options have been introduced and shown to be an effective treatment in many metabolic bone disorders, such as burosumab for hypophosphatemic rickets and asfotase alfa for hypophosphatasia. On the other hand, other disorders, such as nutritional rickets and skeletal fluorosis continue to be underrecognized in many regions of the world. Genetic disorders of collagen-elastin, such as osteogenesis imperfecta, Ehlers--Danlos syndrome and Marfan's syndrome are also associated with skeletal fragility, which can be misdiagnosed as caused by non-accidental trauma\/child abuse.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>It is essential to provide early and accurate diagnosis and treatment for pediatric patients with metabolic bone disorders in order to maintain growth and development as well as prevent fractures and metabolic complications.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/mop.0000000000000914","type":"journal-article","created":{"date-parts":[[2020,7,7]],"date-time":"2020-07-07T09:01:33Z","timestamp":1594112493000},"page":"560-573","source":"Crossref","is-referenced-by-count":23,"title":["Diagnosis and management of pediatric metabolic bone diseases associated with skeletal fragility"],"prefix":"10.1097","volume":"32","author":[{"given":"Nipith","family":"Charoenngam","sequence":"first","affiliation":[{"name":"Department of Medicine, Section of Endocrinology, Nutrition, and Diabetes, Vitamin D, Skin and Bone Research Laboratory, Boston University Medical Center, Boston, Massachusetts, USA"},{"name":"Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammet B.","family":"Cevik","sequence":"additional","affiliation":[{"name":"Department of Medicine, Section of Endocrinology, Nutrition, and Diabetes, Vitamin D, Skin and Bone Research Laboratory, Boston University Medical Center, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael F.","family":"Holick","sequence":"additional","affiliation":[{"name":"Department of Medicine, Section of Endocrinology, Nutrition, and Diabetes, Vitamin D, Skin and Bone Research Laboratory, Boston University Medical Center, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230918","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1172\/JCI29449","article-title":"Resurrection of vitamin D deficiency and rickets","volume":"116","author":"Holick","year":"2006","journal-title":"J Clin Investi"},{"key":"R2-20230918","doi-asserted-by":"crossref","first-page":"17101","DOI":"10.1038\/nrdp.2017.101","article-title":"Rickets","volume":"3","author":"Carpenter","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"R3-20230918","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jsbmb.2012.11.018","article-title":"Nutritional rickets around the world","volume":"136","author":"Prentice","year":"2013","journal-title":"J Steroid Biochem Mol Biol"},{"key":"R4-20230918","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.mayocp.2012.10.018","article-title":"Increasing incidence of nutritional rickets: a population-based study in Olmsted County, Minnesota","volume":"88","author":"Thacher","year":"2013","journal-title":"Mayo Clin Proc"},{"key":"R5-20230918","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1056\/NEJMra070553","article-title":"Vitamin D deficiency","volume":"357","author":"Holick","year":"2007","journal-title":"N Engl J Med"},{"key":"R6-20230918","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1172\/JCI98680","article-title":"CYP3A4 mutation causes vitamin D-dependent rickets type 3","volume":"128","author":"Roizen","year":"2018","journal-title":"J Clin Invest"},{"key":"R7-20230918","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1056\/NEJMcpc0807821","article-title":"Case 3-2009","volume":"360","author":"Holick","year":"2009","journal-title":"New Engl J Med"},{"key":"R8-20230918","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.jcot.2019.07.004","article-title":"Vitamin D for skeletal and nonskeletal health: what we should know","volume":"10","author":"Charoenngam","year":"2019","journal-title":"J Clin Orthopaed Trauma"},{"key":"R9-20230918","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1210\/jc.2011-0385","article-title":"Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline","volume":"96","author":"Holick","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"R10-20230918","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1210\/jc.2010-2704","article-title":"The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know","volume":"96","author":"Ross","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"R11-20230918","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1097\/MED.0b013e328358be97","article-title":"Hypophosphatemic rickets","volume":"19","author":"Baroncelli","year":"2012","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"R12-20230918","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1530\/EJE-08-0818","article-title":"Incidence and prevalence of nutritional and hereditary rickets in southern Denmark","volume":"160","author":"Beck-Nielsen","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"R13-20230918","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1507\/endocrj.EJ15-0275","article-title":"Nationwide survey of fibroblast growth factor 23 (FGF23)-related hypophosphatemic diseases in Japan: prevalence, biochemical data and treatment","volume":"62","author":"Endo","year":"2015","journal-title":"Endocr J"},{"key":"R14-20230918","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1530\/EJE-15-0515","article-title":"Hereditary hypophosphatemia in Norway: a retrospective population-based study of genotypes, phenotypes, and treatment complications","volume":"174","author":"Rafaelsen","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"R15-20230918","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3389\/fendo.2018.00267","article-title":"Physiological actions of fibroblast growth factor-23","volume":"9","author":"Erben","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R16-20230918","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/s41581-019-0152-5","article-title":"Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia","volume":"15","author":"Haffner","year":"2019","journal-title":"Nat Rev Nephrol"},{"key":"R17-20230918","doi-asserted-by":"crossref","first-page":"R53","DOI":"10.1530\/ERC-11-0006","article-title":"Tumor-induced osteomalacia","volume":"18","author":"Chong","year":"2011","journal-title":"Endocr Relat Cancer"},{"key":"R18-20230918","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1002\/jbmr.340","article-title":"A clinician's guide to X-linked hypophosphatemia","volume":"26","author":"Carpenter","year":"2011","journal-title":"J Bone Miner Res"},{"key":"R19-20230918","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1007\/s11999-008-0547-2","article-title":"Deformity correction in children with hereditary hypophosphatemic rickets","volume":"466","author":"Petje","year":"2008","journal-title":"Clin Orthop Relat Res"},{"key":"R20-20230918","doi-asserted-by":"crossref","first-page":"R13","DOI":"10.1530\/EC-13-0103","article-title":"Therapeutic management of hypophosphatemic rickets from infancy to adulthood","volume":"3","author":"Linglart","year":"2014","journal-title":"Endocr Connect"},{"key":"R21-20230918","first-page":"326","article-title":"Pharmaceutical approval update","volume":"43","author":"Choy","year":"2018","journal-title":"P T"},{"key":"R22-20230918","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1056\/NEJMoa1714641","article-title":"Burosumab therapy in children with X-linked hypophosphatemia","volume":"378","author":"Carpenter","year":"2018","journal-title":"New Engl J Med"},{"key":"R23-20230918","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1016\/S0140-6736(19)30654-3","article-title":"Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial","volume":"393","author":"Imel","year":"2019","journal-title":"Lancet"},{"key":"R24-20230918","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1210\/jc.2003-030036","article-title":"Early treatment improves growth and biochemical and radiographic outcome in X-linked hypophosphatemic rickets","volume":"88","author":"M\u00e4kitie","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"R25-20230918","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00467-011-2046-z","article-title":"Growth in PHEX-associated X-linked hypophosphatemic rickets: the importance of early treatment","volume":"27","author":"Quinlan","year":"2012","journal-title":"Pediatr Nephrol"},{"key":"R26-20230918","doi-asserted-by":"crossref","first-page":"e10190","DOI":"10.1002\/jbm4.10190","article-title":"FGF23, hypophosphatemia, and emerging treatments","volume":"3","author":"Imel","year":"2019","journal-title":"JBMR Plus"},{"key":"R27-20230918","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1002\/ajmg.a.35327","article-title":"Analysis of skeletal dysplasias in the Utah population","volume":"158A","author":"Stevenson","year":"2012","journal-title":"Am J Medical Genet A"},{"key":"R28-20230918","doi-asserted-by":"crossref","first-page":"17052","DOI":"10.1038\/nrdp.2017.52","article-title":"Osteogenesis imperfecta","volume":"3","author":"Marini","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"R29-20230918","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11914-016-0299-y","article-title":"Advances in the classification and treatment of osteogenesis imperfecta","volume":"14","author":"Thomas","year":"2016","journal-title":"Curr Osteoporos Rep"},{"key":"R30-20230918","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1136\/jmg.16.2.101","article-title":"Genetic heterogeneity in osteogenesis imperfecta","volume":"16","author":"Sillence","year":"1979","journal-title":"J Med Genet"},{"key":"R31-20230918","doi-asserted-by":"crossref","DOI":"10.1080\/19381980.2017.1279768","article-title":"Multiple fractures in infants who have Ehlers-Danlos\/hypermobility syndrome and or vitamin D deficiency: a case series of 72 infants whose parents were accused of child abuse and neglect","volume":"9","author":"Holick","year":"2017","journal-title":"Dermatoendocrinol"},{"key":"R32-20230918","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/S0140-6736(05)67789-6","article-title":"Marfan's syndrome","volume":"366","author":"Judge","year":"2005","journal-title":"Lancet"},{"key":"R33-20230918","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1093\/hmg\/ddn374","article-title":"Mutation and polymorphism spectrum in osteogenesis imperfecta type II: implications for genotype-phenotype relationships","volume":"18","author":"Bodian","year":"2009","journal-title":"Hum Mol Genet"},{"key":"R34-20230918","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.metabol.2017.06.001","article-title":"Osteogenesis imperfecta x2013: a clinical update","volume":"80","author":"Tournis","year":"2018","journal-title":"Metab Clin Exp"},{"key":"R35-20230918","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/352337a0","article-title":"Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene","volume":"352","author":"Dietz","year":"1991","journal-title":"Nature"},{"key":"R36-20230918","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/ng1392","article-title":"Heterozygous TGFBR2 mutations in Marfan syndrome","volume":"36","author":"Mizuguchi","year":"2004","journal-title":"Nat Genet"},{"key":"R37-20230918","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/ng1511","article-title":"A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2","volume":"37","author":"Loeys","year":"2005","journal-title":"Nat Genet"},{"key":"R38-20230918","doi-asserted-by":"crossref","first-page":"e207","DOI":"10.1097\/BPO.0000000000001137","article-title":"Fracture patterns differ between osteogenesis imperfecta and routine pediatric fractures","volume":"38","author":"Peddada","year":"2018","journal-title":"J Pediatr Orthopaed"},{"key":"R39-20230918","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1056\/NEJM198406283102602","article-title":"Osteogenesis imperfecta after the menopause","volume":"310","author":"Paterson","year":"1984","journal-title":"New Engl J Med"},{"key":"R40-20230918","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1002\/ajmg.a.33448","article-title":"Wormian bones in osteogenesis imperfecta: correlation to clinical findings and genotype","volume":"152A","author":"Semler","year":"2010","journal-title":"Am J Med Genet A"},{"key":"R41-20230918","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1046\/j.1475-1313.2002.00062.x","article-title":"Central corneal thickness is lower in osteogenesis imperfecta and negatively correlates with the presence of blue sclera","volume":"22","author":"Evereklioglu","year":"2002","journal-title":"Ophthalmic Physiol Opt"},{"key":"R42-20230918","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1007\/s00198-018-4663-x","article-title":"Osteogenesis imperfecta and the teeth, eyes, and ears\u2014a study of nonskeletal phenotypes in adults","volume":"29","author":"Hald","year":"2018","journal-title":"Osteoporos Int"},{"key":"R43-20230918","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/s13023-018-0935-y","article-title":"Oral health-related quality of life in children and adolescents with osteogenesis imperfecta: cross-sectional study","volume":"13","author":"Najirad","year":"2018","journal-title":"Orphanet J Rare Dis"},{"key":"R44-20230918","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0176466","article-title":"Mutations in COL1A1 and COL1A2 and dental aberrations in children and adolescents with osteogenesis imperfecta - a retrospective cohort study","volume":"12","author":"Andersson","year":"2017","journal-title":"PLoS One"},{"key":"R45-20230918","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1007\/s00381-008-0602-z","article-title":"Specific entities affecting the craniocervical region","volume":"24","author":"Menezes","year":"2008","journal-title":"Child's Nervous Syst"},{"key":"R46-20230918","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/1750-1172-6-88","article-title":"Osteogenesis Imperfecta: the audiological phenotype lacks correlation with the genotype","volume":"6","author":"Swinnen","year":"2011","journal-title":"Orphanet J Rare Dis"},{"key":"R47-20230918","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.bone.2019.01.022","article-title":"Aortic aneurysm\/dissection and osteogenesis imperfecta: four new families and review of the literature","volume":"121","author":"Balasubramanian","year":"2019","journal-title":"Bone"},{"key":"R48-20230918","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.mehy.2018.03.017","article-title":"Classical metaphyseal lesions thought to be pathognomonic of child abuse are often artifacts or indicative of metabolic bone disease","volume":"115","author":"Miller","year":"2018","journal-title":"Med Hypothes"},{"key":"R49-20230918","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/S0140-6736(04)16051-0","article-title":"Osteogenesis imperfecta","volume":"363","author":"Rauch","year":"2004","journal-title":"The Lancet"},{"key":"R50-20230918","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1136\/jmg.39.6.382","article-title":"Testing for osteogenesis imperfecta in cases of suspected nonaccidental injury","volume":"39","author":"Marlowe","year":"2002","journal-title":"J Med Genet"},{"key":"R51-20230918","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1136\/archdischild-2013-304822","article-title":"Ehlers\u2013Danlos syndrome: how to diagnose and when to perform genetic tests","volume":"100","author":"Sobey","year":"2015","journal-title":"Arch Dis Child"},{"key":"R52-20230918","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/jmg.2009.072785","article-title":"The revised Ghent nosology for the Marfan syndrome","volume":"47","author":"Loeys","year":"2010","journal-title":"J Med Genet"},{"key":"R53-20230918","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1002\/jbmr.2567","article-title":"Intravenous bisphosphonate therapy of young children with osteogenesis imperfecta: skeletal findings during follow up throughout the growing years","volume":"30","author":"Palomo","year":"2015","journal-title":"J Bone Miner Res"},{"key":"R54-20230918","first-page":"e1","article-title":"Systematic review on the incidence of bisphosphonate related osteonecrosis of the jaw in children diagnosed with osteogenesis imperfecta","volume":"4","author":"Hennedige","year":"2014","journal-title":"J Oral Maxillofac Res"},{"key":"R55-20230918","first-page":"24","article-title":"Safety and efficacy of denosumab in children with osteogenesis imperfect--a first prospective trial","volume":"16","author":"Hoyer-Kuhn","year":"2016","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"R56-20230918","doi-asserted-by":"crossref","DOI":"10.1186\/1750-1172-2-40","article-title":"Hypophosphatasia","volume":"2","author":"Mornet","year":"2007","journal-title":"Orphanet J Rare Dis"},{"key":"R57-20230918","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.bone.2017.02.011","article-title":"Hypophosphatasia: an overview for 2017","volume":"102","author":"Whyte","year":"2017","journal-title":"Bone"},{"key":"R58-20230918","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/0002-9343(57)90124-9","article-title":"Hypophosphatasia","volume":"22","author":"Fraser","year":"1957","journal-title":"Am J Med"},{"key":"R59-20230918","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1749-6632.2010.05387.x","article-title":"Physiological role of alkaline phosphatase explored in hypophosphatasia","volume":"1192","author":"Whyte","year":"2010","journal-title":"Ann N Y Acad Sci"},{"key":"R60-20230918","first-page":"280","article-title":"Hyperphosphatemia in infantile hypophosphatasia: implications for carrier diagnosis and screening","volume":"46","author":"Chodirker","year":"1990","journal-title":"Am J Hum Genet"},{"key":"R61-20230918","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s00296-008-0710-9","article-title":"How can calcium pyrophosphate crystals induce inflammation in hypophosphatasia or chronic inflammatory joint diseases?","volume":"29","author":"Beck","year":"2009","journal-title":"Rheumatol Int"},{"key":"R62-20230918","doi-asserted-by":"crossref","first-page":"34","DOI":"10.4274\/jcrpe.473","article-title":"Hypophosphatasia presenting with pyridoxine-responsive seizures, hypercalcemia, and pseudotumor cerebri: case report","volume":"4","author":"Demirbilek","year":"2012","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"R63-20230918","doi-asserted-by":"crossref","first-page":"4606","DOI":"10.1210\/jc.2013-1811","article-title":"Acute severe hypercalcemia after traumatic fractures and immobilization in hypophosphatasia complicated by chronic renal failure","volume":"98","author":"Whyte","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"R64-20230918","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s00223-015-0079-1","article-title":"Alkaline phosphatase and hypophosphatasia","volume":"98","author":"Mill\u00e1n","year":"2016","journal-title":"Calcified Tissue Int"},{"key":"R65-20230918","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/BF01800216","article-title":"Increased plasma pyridoxal-5\u2019-phosphate levels before and after pyridoxine loading in carriers of perinatal\/infantile hypophosphatasia","volume":"13","author":"Chodirker","year":"1990","journal-title":"J Inherit Metab Dis"},{"key":"R66-20230918","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.bone.2015.02.022","article-title":"Hypophosphatasia: validation and expansion of the clinical nosology for children from 25 years experience with 173 pediatric patients","volume":"75","author":"Whyte","year":"2015","journal-title":"Bone"},{"key":"R67-20230918","doi-asserted-by":"crossref","first-page":"230","DOI":"10.11138\/ccmbm\/2017.14.1.230","article-title":"Hypophosphatasia: clinical manifestation and burden of disease in adult patients","volume":"14","author":"Conti","year":"2017","journal-title":"Clin Cases Miner Bone Metab"},{"key":"R68-20230918","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.bone.2016.08.019","article-title":"Hypophosphatasia: natural history study of 101 affected children investigated at one research center","volume":"93","author":"Whyte","year":"2016","journal-title":"Bone"},{"key":"R69-20230918","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1056\/NEJM196909112811107","article-title":"Pseudohypophosphatasia","volume":"281","author":"Scriver","year":"1969","journal-title":"New Engl J Med"},{"key":"R70-20230918","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/s00247-013-2805-z","article-title":"Benign prenatal hypophosphatasia: a treatable disease not to be missed","volume":"44","author":"Matsushita","year":"2014","journal-title":"Pediatr Radiol"},{"key":"R71-20230918","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1002\/jbmr.454","article-title":"Hypophosphatasia: nonlethal disease despite skeletal presentation in utero (17 new cases and literature review)","volume":"26","author":"Wenkert","year":"2011","journal-title":"J Bone Miner Res"},{"key":"R72-20230918","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.2147\/DDDT.S154922","article-title":"Profile of asfotase alfa in the treatment of hypophosphatasia: design, development, and place in therapy","volume":"12","author":"Bowden","year":"2018","journal-title":"Drug Des Devel Ther"},{"key":"R73-20230918","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1056\/NEJMoa1106173","article-title":"Enzyme-replacement therapy in life-threatening hypophosphatasia","volume":"366","author":"Whyte","year":"2012","journal-title":"N Engl J Med"},{"key":"R74-20230918","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s11926-018-0778-5","article-title":"Hypophosphatasia: from diagnosis to treatment","volume":"20","author":"Simon","year":"2018","journal-title":"Curr Rheumatol Rep"},{"key":"R75-20230918","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1002\/jbmr.1565","article-title":"\u2018Atypical femoral fractures\u2019 during bisphosphonate exposure in adult hypophosphatasia","volume":"27","author":"Sutton","year":"2012","journal-title":"J Bone Miner Res"},{"key":"R76-20230918","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1359\/jbmr.2003.18.4.624","article-title":"Marrow cell transplantation for infantile hypophosphatasia","volume":"18","author":"Whyte","year":"2003","journal-title":"J Bone Miner Res"},{"key":"R77-20230918","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1210\/jc.2006-1902","article-title":"Adult hypophosphatasia treated with teriparatide","volume":"92","author":"Whyte","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"R78-20230918","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/j.bone.2007.01.020","article-title":"Pyridoxine-responsive seizures as the first symptom of infantile hypophosphatasia caused by two novel missense mutations (c.677T>C, p.M226T; c. 1112C>T, p. T371I) of the tissue-nonspecific alkaline phosphatase gene","volume":"40","author":"Baumgartner-Sigl","year":"2007","journal-title":"Bone"},{"key":"R79-20230918","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1750-1172-4-5","article-title":"Osteopetrosis","volume":"4","author":"Stark","year":"2009","journal-title":"Orphanet J Rare Dis"},{"key":"R80-20230918","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0022-3476(77)80441-1","article-title":"Osteopetrosis in children: a report of 26 cases","volume":"91","author":"Lor\u00eda-Cort\u00e9s","year":"1977","journal-title":"J Pediatr"},{"key":"R81-20230918","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/8756-3282(88)90021-X","article-title":"Radiological, biochemical and hereditary evidence of two types of autosomal dominant osteopetrosis","volume":"9","author":"Bollerslev","year":"1988","journal-title":"Bone"},{"key":"R82-20230918","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00223-014-9865-4","article-title":"A comparison of osteoclast-rich and osteoclast-poor osteopetrosis in adult mice sheds light on the role of the osteoclast in coupling bone resorption and bone formation","volume":"95","author":"Thudium","year":"2014","journal-title":"Calcified Tissue Int"},{"key":"R83-20230918","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ajhg.2008.06.015","article-title":"Human osteoclast-poor osteopetrosis with hypogammaglobulinemia due to TNFRSF11A (RANK) mutations","volume":"83","author":"Guerrini","year":"2008","journal-title":"Am J Hum Genet"},{"key":"R84-20230918","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1038\/ng2076","article-title":"Osteoclast-poor human osteopetrosis due to mutations in the gene encoding RANKL","volume":"39","author":"Sobacchi","year":"2007","journal-title":"Nat Genet"},{"key":"R85-20230918","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/humu.9266","article-title":"Carbonic anhydrase II deficiency syndrome (osteopetrosis with renal tubular acidosis and brain calcification): novel mutations in CA2 identified by direct sequencing expand the opportunity for genotype-phenotype correlation","volume":"24","author":"Shah","year":"2004","journal-title":"Hum Mutat"},{"key":"R86-20230918","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1515\/jpem-2012-0129","article-title":"Infantile malignant osteopetrosis: a rare cause of neonatal hypocalcemia","volume":"25","author":"Engiz","year":"2012","journal-title":"J Pediatr Endocrinol Metab"},{"key":"R87-20230918","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s00277-002-0578-9","article-title":"Malignant infantile osteopetrosis initially presenting with neonatal hypocalcemia: case report","volume":"82","author":"Chen","year":"2003","journal-title":"Ann Hematol"},{"key":"R88-20230918","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.4081\/hr.2011.e1","article-title":"Osteopetrosis: a rare cause of anemia","volume":"3","author":"Sreehari","year":"2011","journal-title":"Hematol Rep"},{"key":"R89-20230918","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S8756-3282(99)00244-6","article-title":"Type II autosomal dominant osteopetrosis (Albers-Sch\u00f6nberg disease): clinical and radiological manifestations in 42 patients","volume":"26","author":"B\u00e9nichou","year":"2000","journal-title":"Bone"},{"key":"R90-20230918","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1002\/ajmg.a.32253","article-title":"The Erlenmeyer flask bone deformity in the skeletal dysplasias","volume":"149A","author":"Faden","year":"2009","journal-title":"Am J Med Genet A"},{"key":"R91-20230918","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.bonr.2015.11.002","article-title":"A case of infantile osteopetrosis: the radioclinical features with literature update","volume":"4","author":"El-Sobky","year":"2015","journal-title":"Bone Rep"},{"key":"R92-20230918","doi-asserted-by":"crossref","first-page":"55","DOI":"10.4103\/0972-3919.147544","article-title":"Osteopetrosis: radiological & radionuclide imaging","volume":"30","author":"Sit","year":"2015","journal-title":"Indian J Nucl Med"},{"key":"R93-20230918","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1210\/jcem.87.5.8497","article-title":"Measurement of tartrate-resistant acid phosphatase and the brain isoenzyme of creatine kinase accurately diagnoses type II autosomal dominant osteopetrosis but does not identify gene carriers","volume":"87","author":"Waguespack","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"R94-20230918","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/nrendo.2013.137","article-title":"Osteopetrosis: genetics, treatment and new insights into osteoclast function","volume":"9","author":"Sobacchi","year":"2013","journal-title":"Nat Rev Endocrinol"},{"key":"R95-20230918","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.1210\/jc.2017-01127","article-title":"Diagnosis and management of osteopetrosis: consensus guidelines from the Osteopetrosis Working Group","volume":"102","author":"Wu","year":"2017","journal-title":"J Clin Endocrinology Metab"},{"key":"R96-20230918","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1046\/j.1365-2990.2003.00474.x","article-title":"Neurological aspects of osteopetrosis","volume":"29","author":"Steward","year":"2003","journal-title":"Neuropathol Appl Neurobiol"},{"key":"R97-20230918","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/bmt.2009.277","article-title":"Characterization and management of hypercalcemia following transplantation for osteopetrosis","volume":"45","author":"Martinez","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"R98-20230918","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1056\/NEJMc1206193","article-title":"Denosumab for posttransplantation hypercalcemia in osteopetrosis","volume":"367","author":"Shroff","year":"2012","journal-title":"N Engl J Med"},{"key":"R99-20230918","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3746\/pnf.2018.23.3.171","article-title":"The fluoride debate: the pros and cons of fluoridation","volume":"23","author":"Aoun","year":"2018","journal-title":"Prev Nutr Food Sci"},{"key":"R100-20230918","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0950-3579(05)80145-1","article-title":"Endemic fluorosis","volume":"9","author":"McGill","year":"1995","journal-title":"Baillieres Clin Rheumatol"},{"key":"R101-20230918","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1186\/s12889-019-7646-8","article-title":"Fluoride concentration in ground water and prevalence of dental fluorosis in Ethiopian Rift Valley: systematic review and meta-analysis","volume":"19","author":"Demelash","year":"2019","journal-title":"BMC Public Health"},{"key":"R102-20230918","doi-asserted-by":"crossref","DOI":"10.1155\/2009\/969764","article-title":"Child skeletal fluorosis from indoor burning of coal in southwestern China","volume":"2009","author":"Qin","year":"2009","journal-title":"J Environ Public Health"},{"key":"R103-20230918","first-page":"379","article-title":"Prevalence of skeletal fluorosis in fisherman from Kutch coast, Gujarat, India","volume":"66","author":"John","year":"2015","journal-title":"Rocz Panstw Zakl Hig"},{"key":"R104-20230918","doi-asserted-by":"crossref","first-page":"190","DOI":"10.4103\/2230-8210.196013","article-title":"Association of dental and skeletal fluorosis with calcium intake and serum vitamin D concentration in adolescents from a region endemic for fluorosis","volume":"21","author":"Patel","year":"2017","journal-title":"Indian J Endocrinol Metab"},{"issue":"(3\u20134)","key":"R105-20230918","first-page":"279","article-title":"Skeletal fluorosis in humans: a review of recent progress in the understanding of the disease","volume":"10","author":"Krishnamachari","year":"1986","journal-title":"Prog Food Nutr Sci"},{"key":"R106-20230918","doi-asserted-by":"crossref","first-page":"157","DOI":"10.4103\/0019-5049.177867","article-title":"Chronic fluorosis: the disease and its anaesthetic implications","volume":"60","author":"Kurdi","year":"2016","journal-title":"Indian J Anaesth"},{"key":"R107-20230918","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1111\/jcmm.14185","article-title":"The pathogenesis of endemic fluorosis: research progress in the last 5 years","volume":"23","author":"Wei","year":"2019","journal-title":"J Cell Mol Med"},{"key":"R108-20230918","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/BF02685921","article-title":"Fluoride-induced oxidative stress of osteoblasts and protective effects of baicalein against fluoride toxicity","volume":"116","author":"Jin","year":"2007","journal-title":"Biol Trace Elem Res"},{"key":"R109-20230918","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s12011-013-9770-0","article-title":"Fluoride promotes viability and differentiation of osteoblast-like Saos-2 cells via BMP\/Smads signaling pathway","volume":"155","author":"Huo","year":"2013","journal-title":"Biol Trace Elem Res"},{"key":"R110-20230918","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.tox.2014.07.006","article-title":"A role for PERK in the mechanism underlying fluoride-induced bone turnover","volume":"325","author":"Sun","year":"2014","journal-title":"Toxicology"},{"key":"R111-20230918","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s12011-016-0833-x","article-title":"Preliminary analysis of microRNAs expression profiling in MC3T3-E1 cells exposed to fluoride","volume":"176","author":"Wang","year":"2017","journal-title":"Biol Trace Elem Res"},{"key":"R112-20230918","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.etap.2016.08.001","article-title":"Relationship between fluoride exposure and osteoclast markers during RANKL-induced osteoclast differentiation","volume":"46","author":"Junrui","year":"2016","journal-title":"Environ Toxicol Pharmacol"},{"key":"R113-20230918","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s12011-015-0245-3","article-title":"Fluoride affects calcium homeostasis by regulating parathyroid hormone, PTH-related peptide, and calcium-sensing receptor expression","volume":"165","author":"Wang","year":"2015","journal-title":"Biol Trace Elem Res"},{"key":"R114-20230918","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/tox.21784","article-title":"Fluoride decreased osteoclastic bone resorption through the inhibition of NFATc1 gene expression","volume":"29","author":"Pei","year":"2014","journal-title":"Environ Toxicol"},{"key":"R115-20230918","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3892\/ijmm.2013.1576","article-title":"Sodium fluoride induces apoptosis through the downregulation of hypoxia-inducible factor-1\u03b1 in primary cultured rat chondrocytes","volume":"33","author":"Meng","year":"2014","journal-title":"Int J Mol Med"},{"key":"R116-20230918","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.chemosphere.2014.12.090","article-title":"Effects of fluoride on the ultrastructure and expression of Type I collagen in rat hard tissue","volume":"128","author":"Yan","year":"2015","journal-title":"Chemosphere"},{"key":"R117-20230918","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.7812\/TPP\/15-048","article-title":"Image diagnosis: dental and skeletal fluorosis","volume":"20","author":"Gupta","year":"2016","journal-title":"Perm J"},{"key":"R118-20230918","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1001\/archinte.1989.00390030143028","article-title":"Endemic fluorosis with spinal cord compression. A case report and review","volume":"149","author":"Fisher","year":"1989","journal-title":"Arch Intern Med"},{"key":"R119-20230918","doi-asserted-by":"crossref","first-page":"7","DOI":"10.4103\/0028-3886.48793","article-title":"Neurology of endemic skeletal fluorosis","volume":"57","author":"Reddy","year":"2009","journal-title":"Neurol India"},{"key":"R120-20230918","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1136\/pgmj.38.437.150","article-title":"Endemic fluorosis with particular reference to dental and systemic intoxication","volume":"38","author":"Singh","year":"1962","journal-title":"Postgrad Med J"},{"key":"R121-20230918","first-page":"147","article-title":"Treatment and prevention of skeletal fluorosis","volume":"30","author":"Yang","year":"2017","journal-title":"Biomed Environ Sci"},{"key":"R122-20230918","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1442-200X.1996.tb03536.x","article-title":"Reversal of fluorosis in children","volume":"38","author":"Gupta","year":"1996","journal-title":"Acta Paediatr Jpn"}],"container-title":["Current Opinion in Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MOP.0000000000000914","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T22:28:08Z","timestamp":1694989688000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MOP.0000000000000914"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":122,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/mop.0000000000000914","relation":{},"ISSN":["1040-8703","1531-698X"],"issn-type":[{"value":"1040-8703","type":"print"},{"value":"1531-698X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8]]}}}